# Universal Health Realty Income Trust: filings

UHT · NYSE · CIK 798783 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uht.md) · [Financials](/companies/uht/financials.md) · [Filings](/companies/uht/filings.md) · [Insiders](/companies/uht/insiders.md)

## Reports and events: 217 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 222, 8-K 125, 10-Q 53, SC 13G/A 43, 10-K 18, DEF 14A 18, DEFA14A 18, UPLOAD 14, ARS 11, CORRESP 10, 3 7, 424B2 5, SC 13G 5, EFFECT 4, S-3 4, 8-K/A 3, S-8 3, SCHEDULE 13G/A 3, 424B5 2, S-3ASR 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 16:25 ET | [8-K](/filings/0001193125-26-434277.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-434277 |
| 2026-08-07 | 16:15 ET | [10-Q](/filings/0001193125-26-340281.md) | Quarterly report, period 2026-06-30 | 0001193125-26-340281 |
| 2026-07-27 | 16:25 ET | [8-K](/filings/0001193125-26-318144.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-318144 |
| 2026-06-11 | 16:15 ET | [8-K](/filings/0001193125-26-267569.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-267569 |
| 2026-05-07 | 16:17 ET | [10-Q](/filings/0001193125-26-211984.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211984 |
| 2026-04-28 | 06:30 ET | [DEF 14A](/filings/0001193125-26-183412.md) | Proxy statement, period 2026-06-10 | 0001193125-26-183412 |
| 2026-04-27 | 16:25 ET | [8-K](/filings/0001193125-26-182162.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-182162 |
| 2026-04-24 | 08:15 ET | [8-K](/filings/0001193125-26-175196.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-175196 |
| 2026-02-25 | 16:25 ET | [8-K](/filings/0001193125-26-071714.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071714 |
| 2026-02-25 | 16:16 ET | [10-K](/filings/0001193125-26-071594.md) | Annual report, period 2025-12-31 | 0001193125-26-071594 |
| 2025-11-07 | 16:15 ET | [10-Q](/filings/0001193125-25-272382.md) | Quarterly report, period 2025-09-30 | 0001193125-25-272382 |
| 2025-10-27 | 16:25 ET | [8-K](/filings/0001193125-25-251645.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-251645 |
| 2025-08-08 | 16:15 ET | [10-Q](/filings/0001193125-25-177000.md) | Quarterly report, period 2025-06-30 | 0001193125-25-177000 |
| 2025-07-28 | 16:30 ET | [8-K](/filings/0000950170-25-099202.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-099202 |
| 2025-06-12 | 16:20 ET | [8-K](/filings/0000950170-25-085399.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-25-085399 |
| 2025-05-08 | 16:16 ET | [10-Q](/filings/0000950170-25-067009.md) | Quarterly report, period 2025-03-31 | 0000950170-25-067009 |
| 2025-04-28 | 16:25 ET | [8-K](/filings/0000950170-25-059340.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-059340 |
| 2025-04-25 | 06:30 ET | [DEF 14A](/filings/0000950170-25-058306.md) | Proxy statement, period 2025-06-11 | 0000950170-25-058306 |
| 2025-02-26 | 16:50 ET | [8-K](/filings/0000950170-25-027870.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-027870 |
| 2025-02-26 | 16:47 ET | [10-K](/filings/0000950170-25-027861.md) | Annual report, period 2024-12-31 | 0000950170-25-027861 |
| 2024-11-08 | 16:20 ET | [10-Q](/filings/0000950170-24-124121.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124121 |
| 2024-10-24 | 16:20 ET | [8-K](/filings/0000950170-24-117069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-117069 |
| 2024-10-02 | 11:13 ET | [8-K](/filings/0001193125-24-230879.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-230879 |
| 2024-08-08 | 16:20 ET | [10-Q](/filings/0000950170-24-094044.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094044 |
| 2024-07-24 | 16:25 ET | [8-K](/filings/0000950170-24-086074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-086074 |
| 2024-06-06 | 16:15 ET | [8-K](/filings/0000950170-24-069899.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-24-069899 |
| 2024-05-08 | 16:20 ET | [10-Q](/filings/0000950170-24-055718.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055718 |
| 2024-04-24 | 16:20 ET | [8-K](/filings/0000950170-24-047606.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-047606 |
| 2024-04-23 | 06:30 ET | [DEF 14A](/filings/0001193125-24-105818.md) | Proxy statement, period 2024-06-05 | 0001193125-24-105818 |
| 2024-02-27 | 16:25 ET | [8-K](/filings/0000950170-24-021213.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021213 |
| 2024-02-27 | 16:20 ET | [10-K](/filings/0000950170-24-021191.md) | Annual report, period 2023-12-31 | 0000950170-24-021191 |
| 2023-11-08 | 16:20 ET | [10-Q](/filings/0000950170-23-061157.md) | Quarterly report, period 2023-09-30 | 0000950170-23-061157 |
| 2023-10-25 | 16:30 ET | [8-K](/filings/0000950170-23-055221.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-055221 |
| 2023-08-08 | 16:24 ET | [10-Q](/filings/0000950170-23-039868.md) | Quarterly report, period 2023-06-30 | 0000950170-23-039868 |
| 2023-07-25 | 16:42 ET | [8-K](/filings/0000950170-23-034455.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-034455 |
| 2023-06-08 | 16:10 ET | [8-K](/filings/0000950170-23-027006.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-23-027006 |
| 2023-05-16 | 16:28 ET | [8-K](/filings/0000950170-23-022481.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-23-022481 |
| 2023-05-09 | 09:11 ET | [10-Q](/filings/0000950170-23-019195.md) | Quarterly report, period 2023-03-31 | 0000950170-23-019195 |
| 2023-04-25 | 16:43 ET | [8-K](/filings/0000950170-23-014481.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-014481 |
| 2023-04-25 | 06:16 ET | [DEF 14A](/filings/0001193125-23-113887.md) | Proxy statement | 0001193125-23-113887 |
| 2023-02-27 | 16:34 ET | [8-K](/filings/0000950170-23-004677.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-004677 |
| 2023-02-27 | 16:17 ET | [10-K](/filings/0000950170-23-004655.md) | Annual report, period 2022-12-31 | 0000950170-23-004655 |
| 2022-12-01 | 16:15 ET | [8-K](/filings/0001564590-22-038816.md) | 5.02 Departure or appointment of officers or directors | 0001564590-22-038816 |
| 2022-11-08 | 16:06 ET | [10-Q](/filings/0001564590-22-037037.md) | Quarterly report, period 2022-09-30 | 0001564590-22-037037 |
| 2022-10-25 | 16:52 ET | [8-K](/filings/0001564590-22-035131.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-035131 |
| 2022-08-08 | 16:16 ET | [10-Q](/filings/0001564590-22-028444.md) | Quarterly report, period 2022-06-30 | 0001564590-22-028444 |
| 2022-07-25 | 16:30 ET | [8-K](/filings/0001564590-22-026321.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-026321 |
| 2022-06-09 | 16:15 ET | [8-K](/filings/0001564590-22-022872.md) | 5.07 Shareholder vote results | 0001564590-22-022872 |
| 2022-05-06 | 16:00 ET | [10-Q](/filings/0001564590-22-018568.md) | Quarterly report, period 2022-03-31 | 0001564590-22-018568 |
| 2022-04-26 | 06:17 ET | [DEF 14A](/filings/0001193125-22-118718.md) | Proxy statement, period 2022-06-08 | 0001193125-22-118718 |

Page 1 of 5. [Older](/companies/uht/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:26 ET. No prices; not investment advice.